Dianthus Therapeutics (NASDAQ:DNTH) announced its Q4 earnings on Monday, March 9, 2026 at 07:09 AM.
Here’s a breakdown of the earnings report.
Earnings
Dianthus Therapeutics missed estimated earnings by -41.58%, reporting an EPS of $-1.43 versus an estimate of $-1.01.
Revenue was down $1.04 million from the same period last year.
Analysis of Past Earnings
In the previous quarter, the company missed on EPS by …